Illumina Body Map 2
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
IRF7 | hg19_v2_chr11_-_615570_615728 | -0.54 | 1.6e-03 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr12_-_91574142 Show fit | 9.56 |
ENST00000547937.1
|
decorin |
|
chr2_-_151344172 Show fit | 6.87 |
ENST00000375734.2
ENST00000263895.4 ENST00000454202.1 |
Rho family GTPase 3 |
|
chr6_-_46889694 Show fit | 6.47 |
ENST00000283296.7
ENST00000362015.4 ENST00000456426.2 |
G protein-coupled receptor 116 |
|
chr4_+_41614909 Show fit | 6.02 |
ENST00000509454.1
ENST00000396595.3 ENST00000381753.4 |
LIM and calponin homology domains 1 |
|
chr11_-_2160180 Show fit | 5.85 |
ENST00000381406.4
|
insulin-like growth factor 2 (somatomedin A) |
|
chr12_+_19358228 Show fit | 5.68 |
ENST00000424268.1
ENST00000543806.1 |
pleckstrin homology domain containing, family A member 5 |
|
chr1_-_85870177 Show fit | 5.64 |
ENST00000542148.1
|
dimethylarginine dimethylaminohydrolase 1 |
|
chr11_-_111794446 Show fit | 5.44 |
ENST00000527950.1
|
crystallin, alpha B |
|
chr2_-_216240386 Show fit | 5.42 |
ENST00000438981.1
|
fibronectin 1 |
|
chr3_+_119316721 Show fit | 5.40 |
ENST00000488919.1
ENST00000495992.1 |
phospholipase A1 member A |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.9 | 28.5 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
0.1 | 17.3 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.0 | 11.2 | GO:0031032 | actomyosin structure organization(GO:0031032) |
0.5 | 10.4 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
1.0 | 10.2 | GO:1990504 | dense core granule exocytosis(GO:1990504) |
0.4 | 10.1 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.0 | 9.1 | GO:0045727 | positive regulation of translation(GO:0045727) |
0.0 | 9.0 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
0.6 | 8.7 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.2 | 8.6 | GO:0036150 | phosphatidylserine acyl-chain remodeling(GO:0036150) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.9 | 28.5 | GO:0005589 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.7 | 22.6 | GO:0005614 | interstitial matrix(GO:0005614) |
0.1 | 17.3 | GO:0030018 | Z disc(GO:0030018) |
0.1 | 10.4 | GO:0005923 | bicellular tight junction(GO:0005923) |
0.3 | 10.1 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.1 | 9.7 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.1 | 8.2 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.1 | 8.0 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 7.0 | GO:0032420 | stereocilium(GO:0032420) |
0.2 | 6.7 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 26.1 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.1 | 25.6 | GO:0008201 | heparin binding(GO:0008201) |
0.0 | 20.9 | GO:0005509 | calcium ion binding(GO:0005509) |
0.4 | 18.8 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.4 | 14.2 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.1 | 14.2 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.2 | 12.8 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.0 | 11.3 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
1.4 | 10.1 | GO:0052739 | phosphatidylserine 1-acylhydrolase activity(GO:0052739) |
0.7 | 9.9 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 32.0 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 23.0 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.2 | 16.5 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.2 | 9.8 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 9.8 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.2 | 8.6 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.1 | 7.5 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 7.1 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.1 | 6.4 | PID SHP2 PATHWAY | SHP2 signaling |
0.1 | 6.2 | PID LKB1 PATHWAY | LKB1 signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 28.3 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.4 | 12.9 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.4 | 10.9 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 8.6 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.3 | 8.3 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.3 | 8.2 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.2 | 6.9 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.1 | 6.5 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.3 | 6.1 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.2 | 6.0 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |